N-Formyl-Nle-Leu-Phe-Nle-Tyr-Lys-100 mg

Description

N-Formyl-Nle-Leu-Phe-Nle-Tyr-Lys TFA (For-Nle-Leu-Phe-Nle-Tyr-Lys-OH TFA) is a formyl peptide receptor (FPR) agonist[1].–80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)–COVID-19-immunoregulation–C43H65N7O9—-[1]Stenfeldt AL, et al. The non-steroidal anti-inflammatory drug piroxicam blocks ligand binding to the formyl peptidereceptor but not the formyl peptide receptor like 1. Biochem Pharmacol. 2007 Oct 1;74(7):1050-6.–71901-21-8–824.02–98.86–NCCCC[C@@H](C(O)=O)NC([C@H](CC1=CC=C(O)C=C1)NC([C@H](CCCC)NC([C@H](CC2=CC=CC=C2)NC([C@H](CC(C)C)NC([C@H](CCCC)NC=O)=O)=O)=O)=O)=O–Inflammation/Immunology–H2O : 16.67 mg/mL (ultrasonic;adjust pH to 12 with NaOH)–Formyl Peptide Receptor (FPR)—-GPCR/G Protein–Peptides